Systemic Connective Tissue Disorders

DBCOND0092168Musculoskeletal and Connective Tissue Diseases

Systemic Connective Tissue Disorders is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Also known as
Connective tissue disorders NEC · Connective tissue disorders (excl congenital) · Connective Tissue Diseases · Connective Tissue Disease · Connective Tissue Disorders
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0005027ICD-10M35SNOMED CT105969002MedDRA10010761UMLSC0009782

What you can answer from here — as of October 22, 2026

1Indicated drugWith each drug's targets and mechanism
Listed above
1Structured indicationPopulation, line of therapy, route and combination as fields, not prose
Sign in
114Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Drug reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Systemic Connective Tissue Disorders share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In